28.48
price up icon3.67%   0.9854
 
loading
Simulations Plus Inc stock is traded at $28.48, with a volume of 74,960. It is up +3.67% in the last 24 hours and down -5.69% over the past month. Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
See More
Previous Close:
$27.49
Open:
$27.38
24h Volume:
74,960
Relative Volume:
0.47
Market Cap:
$565.29M
Revenue:
$66.98M
Net Income/Loss:
$9.65M
P/E Ratio:
56.95
EPS:
0.5
Net Cash Flow:
$10.19M
1W Performance:
-4.20%
1M Performance:
-5.69%
6M Performance:
-38.97%
1Y Performance:
-21.90%
1-Day Range:
Value
$27.38
$28.58
1-Week Range:
Value
$27.22
$29.60
52-Week Range:
Value
$27.22
$51.22

Simulations Plus Inc Stock (SLP) Company Profile

Name
Name
Simulations Plus Inc
Name
Phone
661-723-7723
Name
Address
42505 10TH STREET WEST, LANCASTER, CA
Name
Employee
247
Name
Next Earnings Date
2024-10-23
Name
Latest SEC Filings
Name
SLP's Discussions on Twitter

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Date Action Analyst Rating Change
May-09-23 Initiated BTIG Research Buy
Oct-26-21 Upgrade Craig Hallum Hold → Buy
Jan-12-21 Downgrade Craig Hallum Buy → Hold
Oct-16-20 Initiated Raymond James Outperform
Sep-08-20 Initiated Oppenheimer Outperform
Jan-06-20 Initiated Craig Hallum Buy
View All

Simulations Plus Inc Stock (SLP) Latest News

pulisher
10:08 AM

Insider Selling: Simulations Plus, Inc. (NASDAQ:SLP) Director Sells 20,000 Shares of Stock - MarketBeat

10:08 AM
pulisher
08:57 AM

Simulations Plus director Walter Woltosz sells $553,200 in stock - Investing.com

08:57 AM
pulisher
08:06 AM

Simulations Plus director Walter Woltosz sells $553,200 in stock By Investing.com - Investing.com UK

08:06 AM
pulisher
Nov 04, 2024

Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by StockNews.com - MarketBeat

Nov 04, 2024
pulisher
Nov 01, 2024

Conestoga Capital Advisors LLC Trims Stock Position in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Simulations Plus secures FDA grant for drug testing tech By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 30, 2024

Simulations Plus (NASDAQ:SLP) Sets New 12-Month LowTime to Sell? - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Simulations Plus stock hits 52-week low at $29.32 amid market shifts - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Simulations Plus secures FDA grant for drug testing tech - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - The Bakersfield Californian

Oct 30, 2024
pulisher
Oct 30, 2024

Biosimulation Market is expected to Double Its Size by Upcoming - openPR

Oct 30, 2024
pulisher
Oct 28, 2024

Tributary Capital Management LLC Buys 115,122 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Brokers Offer Predictions for SLP Q2 Earnings - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Q2 Earnings Forecast for SLP Issued By William Blair - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Simulations Plus, Inc. (NASDAQ:SLP) Receives $56.00 Consensus Price Target from Analysts - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Simulations Plus (NASDAQ:SLP) Posts Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Simulations Plus's SWOT analysis: biosimulation leader faces valuation hurdles - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

BTIG cuts Simulations Plus stock price target By Investing.com - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus (NASDAQ:SLP) Receives "Outperform" Rating from William Blair - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus's SWOT analysis: biosimulation leader faces valuation hurdles By Investing.com - Investing.com UK

Oct 24, 2024
pulisher
Oct 24, 2024

How To Trade (SLP) - Stock Traders Daily

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus (NASDAQ:SLP) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus (NASDAQ:SLP) Price Target Cut to $50.00 by Analysts at BTIG Research - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus, Inc. (NASDAQ:SLP) Q4 2024 Earnings Call Transcript - Insider Monkey

Oct 24, 2024
pulisher
Oct 24, 2024

BTIG cuts Simulations Plus stock price target - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus price target lowered to $50 from $60 at BTIG - Nasdaq

Oct 24, 2024
pulisher
Oct 24, 2024

Earnings call: Simulations Plus reports robust FY 2024 results, optimistic FY 2025 - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ... - Yahoo Finance

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Str - GuruFocus.com

Oct 24, 2024
pulisher
Oct 24, 2024

Simulations Plus: Fiscal Q4 Earnings Snapshot - mySA

Oct 24, 2024
pulisher
Oct 23, 2024

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results - BioSpace

Oct 23, 2024
pulisher
Oct 23, 2024

Simulations Plus (SLP) Surpasses Q4 Earnings Estimates - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Simulations Plus (NASDAQ:SLP) Updates FY 2025 Earnings Guidance - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Simulations Plus Reports 18% Revenue Increase for 2024 - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

Simulations Plus sees FY25 adjusted EPS $1.07-$1.20, consensus 63c - Nasdaq

Oct 23, 2024
pulisher
Oct 22, 2024

What to Expect from Simulations Plus's Earnings - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

In A Strategic Move, John Anthony DiBella Acquires Simulations Plus Stock Options: Enhancing Value - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Capitalizing In Growth Prospects, Daniel Szot Acquires In Simulations Plus Stock Options - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Daniel Szot Backs Up Beliefs With A Notable Acquisition In Simulations Plus Stock Options - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Strategic Move: Jill Fiedler-Kelly Enhances Portfolio With Simulations Plus Stock Options - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Capitalizing In Growth Prospects, Shawn O'Connor Acquires In Simulations Plus Stock Options - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

Simulations Plus (SLP) Fell Due to EBITDA Below Expectations - Insider Monkey

Oct 22, 2024
pulisher
Oct 16, 2024

Simulations Plus (SLP) Set to Announce Earnings on Wednesday - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Simulations Plus, Inc. (NASDAQ:SLP) Short Interest Update - MarketBeat

Oct 15, 2024

Simulations Plus Inc Stock (SLP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Simulations Plus Inc Stock (SLP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
WOLTOSZ WALTER S
Director
Oct 01 '24
Sale
31.26
20,000
625,200
3,481,592
WEINER DANIEL L
Director
Sep 27 '24
Sale
31.54
750
23,655
6,994
$19.10
price down icon 0.73%
health_information_services EVH
$23.52
price up icon 0.72%
$16.81
price up icon 0.48%
health_information_services WAY
$28.69
price up icon 0.02%
health_information_services RCM
$14.28
price down icon 0.04%
health_information_services HQY
$86.88
price up icon 0.02%
Cap:     |  Volume (24h):